FDA Inspection 1068353 — Integrated Commercialization Solutions LLC
The FDA completed an inspection of Integrated Commercialization Solutions LLC on September 13, 2018 in Lockbourne, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lockbourne, OH (United States)